Please login to the form below

Not currently logged in
Email:
Password:

Former Astellas regulatory lead joins Oxular

Robert Waters becomes regulatory affairs VP

Oxford, UK-based retinal therapeutics specialist Oxular has appointed Robert Waters as vice president of regulatory affairs.

Waters brings over 15 years of expertise in the development and registration of products in ophthalmology to the firm, most recently as global regulatory lead for urology and ophthalmology projects at Astellas.

Prior to this, Waters served as head of European regulatory affairs development and head of emerging markets, EMEA at Allergan, having previously been its head of ophthalmology and head of regulatory development.

Tom Cavanagh, chief executive of Oxular, said: “We are delighted to welcome Robert to the Oxular team.

“Robert's deep knowledge in global regulation combined with his extensive experience in progressing ophthalmology projects to approval will be a great asset to the Company as we look to bring new ophthalmic products to market.

“As a young company, we are proud to attract somebody of Robert's calibre within the ophthalmology field and we believe that he will play a key role in helping us to achieve our goal of building a global ophthalmic franchise based on the successful development and commercialisation of our innovative and much needed treatments for retinal diseases.”

19th December 2016

From: Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
90TEN

90TEN is an award-winning healthcare communications consultancy that puts people at the heart of everything we do. Our Life.Changing. campaigns...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics